|
1
|
Casulo C, Friedberg J, Ahn K, Flowers C, DiGilio A. AUTOLOGOUS TRANSPLANTATION IMPROVES SURVIVAL IN PATIENTS WITH FOLLICULAR LYMPHOMA EXPERIENCING EARLY THERAPY FAILURE AFTER FRONTLINE CHEMOIMMUNOTHERAPY: AN NLCS AND CIBMTR ANALYSIS. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_86] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- C. Casulo
- Medicine/Hematology/Oncology; University of Rochester; Rochester USA
| | - J.W. Friedberg
- Medicine/Hematology/Oncology; University of Rochester; Rochester USA
| | - K.W. Ahn
- Medicine, Medical College of Wisconsin; Milwaukee USA
| | - C.R. Flowers
- Hematology and Medical Oncology; Emory University Hospital; Atlanta USA
| | - A. DiGilio
- Statistical Center, CIBMTR; Milwaukee USA
| |
Collapse
|
|
2
|
O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers MED, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D. Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. Bone Marrow Transplant 2016; 51:1599-1601. [PMID: 27526284 DOI: 10.1038/bmt.2016.215] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- P V O'Donnell
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Massachusetts General Hospital Cancer Center, Boston, MA, USA
| | - M Eapen
- Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - M M Horowitz
- Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - B R Logan
- Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - A DiGilio
- Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - C Brunstein
- Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
| | - E J Fuchs
- Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
| | - M E D Flowers
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - R Salit
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - K Raj
- Guy's and St. Thomas' Hospitals NHS Hospitals Foundation Trusts, London, UK.,Department of Haematological Medicine, King's College Hospital, London, UK
| | - A Pagliuca
- Department of Haematological Medicine, King's College Hospital, London, UK
| | - K Bradstock
- Department of Hematology, Westmead Hospital, Westmead, New South Wales, Australia
| | - A Granata
- Department of Hematology, Institut Paoli Calmettes (IPC), Aix Marseille University (AMU), UM105, Centre de Reserche en Cancerologie (CRCM), Inserm U1068, CNRS UMR7258, Marseille, France
| | - L Castagna
- Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy
| | - S Furst
- Department of Hematology, Institut Paoli Calmettes (IPC), Aix Marseille University (AMU), UM105, Centre de Reserche en Cancerologie (CRCM), Inserm U1068, CNRS UMR7258, Marseille, France
| | - D Blaise
- Department of Hematology, Institut Paoli Calmettes (IPC), Aix Marseille University (AMU), UM105, Centre de Reserche en Cancerologie (CRCM), Inserm U1068, CNRS UMR7258, Marseille, France
| |
Collapse
|